Company page
Dbv Technologies Sa
Dbv Technologies Sa is a public company based in France, trading under the ticker DBV. The company has a market capitalization of approximately €956.42 million. Dbv Technologies focuses on developing innovative therapies for food allergies and other immunological conditions.
- Ticker
- DBV:EURONEXT
- Asset type
- Stock
- Market cap
- $956.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR